Mangoceuticals (MGRX) News Today $2.48 +0.04 (+1.64%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mangoceuticals Expands with Patent Acquisition in NutraceuticalsDecember 20 at 8:38 AM | markets.businessinsider.comMangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentDecember 19 at 5:33 PM | globenewswire.comMangoceuticals, Inc. (MGRX) Latest Stock News & Headlines - Yahoo FinanceDecember 6, 2024 | finance.yahoo.comMangoceuticals initiates investigation into potential stock manipulationDecember 5, 2024 | markets.businessinsider.comMangoceuticals Signs Consulting Deal with CFO JohnstonNovember 14, 2024 | markets.businessinsider.comMangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNovember 1, 2024 | markets.businessinsider.comMangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History - Yahoo FinanceOctober 26, 2024 | ca.finance.yahoo.comMangoceuticals board initiates process to evaluate strategic alternativesOctober 22, 2024 | markets.businessinsider.comMangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 22, 2024 | finanznachrichten.deMangoceuticals Defends Against Eli Lilly AllegationsOctober 22, 2024 | markets.businessinsider.comMangoceuticals refutes claims made by Lilly in weight-loss drug lawsuitOctober 22, 2024 | seekingalpha.comMangoRx Announces Formation of Strategy and Alternatives CommitteeOctober 22, 2024 | finance.yahoo.comMangoceuticals Opts For Strategic AlternativesOctober 22, 2024 | markets.businessinsider.comMangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 21, 2024 | globenewswire.comStock Splits Do Matter and Here's What's Coming NextOctober 16, 2024 | 247wallst.comMangoceuticals announces 1-for-15 reverse stock splitOctober 13, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | globenewswire.comMangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss SolutionsOctober 3, 2024 | globenewswire.comShares of Healthcare Company Rise Following Product Availability AnnouncementOctober 1, 2024 | msn.comHealthcare Shares Rise Following Product Availability AnnouncementOctober 1, 2024 | theglobeandmail.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | finance.yahoo.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | globenewswire.comMangoceuticals Second Quarter 2024 Earnings: US$0.092 loss per share (vs US$0.14 loss in 2Q 2023)August 18, 2024 | finance.yahoo.comMangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024August 15, 2024 | globenewswire.comMangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology PatentAugust 14, 2024 | markets.businessinsider.comMangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and TirzepatideAugust 9, 2024 | globenewswire.comMangoceuticals: MangoRx Receives Request for Proposal From ISFLST for New Male Enhancement Product Exclusive for the Asian MarketAugust 8, 2024 | finanznachrichten.deMangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention TechnologyJuly 24, 2024 | globenewswire.comMangoceuticals CEO Jacob Cohen Featured on Benzinga All-AccessJuly 18, 2024 | globenewswire.comMangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via SurescriptsJuly 16, 2024 | globenewswire.comMangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation DepartmentJuly 12, 2024 | globenewswire.comMangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging MarketsJuly 11, 2024 | globenewswire.comMangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyJune 6, 2024 | globenewswire.comMangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont TechnologiesJune 4, 2024 | globenewswire.comMangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American MarketsMay 28, 2024 | globenewswire.comMangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing EffortsMay 23, 2024 | globenewswire.comMove Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.May 23, 2024 | investorplace.comWhy Is Mangoceuticals (MGRX) Stock Up 130% Today?May 21, 2024 | investorplace.comMangoceuticals, Inc.: MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 MedicationsMay 21, 2024 | finanznachrichten.deMangoceuticals Develops Oral GLP-1s: Stock SoarsMay 21, 2024 | msn.comMangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 MedicationsMay 21, 2024 | globenewswire.comMangoceuticals, Inc.: MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market PenetrationMay 17, 2024 | finanznachrichten.deMGRX Stock Earnings: Mangoceuticals Reported Results for Q1 2024May 16, 2024 | investorplace.comMangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market PenetrationMay 16, 2024 | globenewswire.comMangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity RequirementMay 2, 2024 | finance.yahoo.comMangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity RequirementMay 2, 2024 | globenewswire.comMangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareApril 25, 2024 | finance.yahoo.comMangoceuticals partners with Emifarma for ED product developmentApril 13, 2024 | investing.comMangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsApril 12, 2024 | globenewswire.com Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. MGRX Media Mentions By Week MGRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGRX News Sentiment▼0.740.60▲Average Medical News Sentiment MGRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGRX Articles This Week▼21▲MGRX Articles Average Week Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CCM News MRAI News PMD News TOI News BRTX News OPGN News KDLY News OTRK News ATPC News VSEE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGRX Stock Alerts